A phase II/III extension study to evaluate the safety and tolerability of atrasentan
Phase of Trial: Phase II/III
Latest Information Update: 28 Nov 2007
At a glance
- Drugs Atrasentan (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- Sponsors Abbott Laboratories
- 28 Nov 2007 Status changed from in progress to completed.
- 09 Feb 2006 New trial record.